San Francisco, California, United States In 2005 was created California Institute for Regenerative Medicine, which is appeared as Corporate Investor. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the San Francisco.
Opposing the other organizations, this California Institute for Regenerative Medicine works on 35 percentage points more the average amount of lead investments. Considering the real fund results, this Corporate Investor is 71 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2013.
The overall number of key employees were 3.
Among the various public portfolio startups of the fund, we may underline Orchard Therapeutics, VistaGen Therapeutics, Sangamo Therapeutics Besides, a startup needs to be aged 11-15 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Clinical Trials, Medical Device. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low.
The usual cause for the fund is to invest in rounds with 1 partaker. Despite the California Institute for Regenerative Medicine, startups are often financed by Sanderling Ventures, Malin Corporation, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by W.L. Gore & Associates, Vivo Capital, Temasek Holdings.
Related Funds
| Fund Name | Location |
| Aivi Invest | - |
| Arcadian Investment Partners | New York, New York, United States |
| Bank El Etihad | Amman, Amman, Jordan |
| Be Angels | Belgium, Louvain-la-neuve, Vlaams-Brabant |
| Disruptive Capital Finance | England, London, United Kingdom |
| DMC Stratex Networks | California, San Jose, United States |
| E Fund Management Co.,LTD. | China, Hong Kong, Hong Kong Island |
| EnerNOC | Boston, Massachusetts, United States |
| Food+Tech Connect | New York, New York, United States |
| Higginbotham Strategic Investments | - |
| Humanwell | China, Hubei, Wuhan |
| Jumbo Sheen Group | China, Guangdong, Shenzhen |
| Presight Capital | New City, New York, United States |
| Rock Springs Capital | Baltimore, Maryland, United States |
| Siddhivinayak Skyscrapers | - |
| WANDA Group | Beijing, Beijing, China |
| Yabeo Capital | Bavaria, Bayern, Germany |
| Zhongyan Chuangxin Touzi | China, Guangdong, Shenzhen |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 